바이오테크 보도자료
-
- Boehringer Ingelheim Extends the Use of Medidata Rave for Electronic Data Capture in Clinical Trials
- Medidata, a Dassault Systèmes company, and Boehringer Ingelheim today announced a five-year renewal of their collaboration in the wider area of electronic data capture. The new agreement extends the use of R...
- 2022년 10월 28일
-
- Merck Showcases Depth of MS Portfolio at ECTRIMS Supporting Commitment to Advancing MS Care
- Merck, a leading science and technology company, today announced it will present 39 abstracts at the 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), being ...
- 2022년 10월 26일
-
- Merck Highlights New Data for Evobrutinib, First BTKi to Demonstrate Sustained Clinical Benefit for People with RMS through Three and a Half Years of Treatment
- Merck, a leading science and technology company, today announced findings which demonstrated that annualized relapse rates (ARR) remained low and Expanded Disability Status Scale (EDSS) scores were stable in...
- 2022년 10월 26일
-
- Ferring Presents Seven New Analyses at ACG 2022 for RBX2660, Its Investigational Microbiota-Based Live Biotherapeutic
- Ferring Pharmaceuticals today announced the presentation at the American College of Gastroenterology (ACG) 2022 Annual Scientific Meeting of seven analyses for RBX2660, an investigational microbiota-based li...
- 2022년 10월 25일
-
- Neuraptive Therapeutics Announces Key Organizational Updates to Support the Company’s Advancements in Nerve Repair
- Neuraptive Therapeutics, Inc., a biotechnology company dedicated to developing novel therapeutics and medical products to address the unmet needs of physicians and patients impacted by peripheral nerve injur...
- 2022년 10월 25일
-
- Biotechs, Developing Countries Vaccine Manufacturers and Pharma Unite Behind a Proposal to G20 and G7 Offering a Practical Solution for Better Access to Vaccines for Future Pandemics
- The Biotechnology Innovation Organization (BIO), Developing Countries Vaccine Manufacturers’ Network (DCVMN) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) have bee...
- 2022년 10월 25일
-
- GQC Is Born: the First Start-up, Federated by PQE Group, to Support Medical Cannabis
- The world's first start-up to support pharmaceutical companies in every aspect of medical cannabis development and distribution is Italian. Named GQC - Glocal Quality Cannabis, it is one of the federated com...
- 2022년 10월 24일
-
- Ferring Presents New Subgroup Analyses of Health-Related Quality of Life and Safety and Efficacy Data at IDWeek 2022 for RBX2660, Its Investigational Microbiota-based Live Biotherapeutic
- Ferring Pharmaceuticals today announced the presentation of two subgroup analyses at Infectious Disease Week (IDWeek) 2022 that further characterize RBX2660, an investigational microbiota-based live biothera...
- 2022년 10월 21일
-
- University of Tübingen and Boehringer Ingelheim Join Forces to Lead AI and Data Science R&D for New Medical Breakthroughs
- University of Tübingen, a leading member of Cyber Valley, Europe’s largest Artificial Intelligence (AI) research consortium and Boehringer Ingelheim launch an AI and data science fellowship program for top t...
- 2022년 10월 21일
-
- Takeda Enters Collaboration and Licensing Agreement with Zedira and Dr. Falk Pharma to Develop First-in-Class Celiac Disease Therapy
- Takeda (TSE:4502/NYSE:TAK), Zedira and Dr. Falk Pharma GmbH today announced a collaboration and licensing agreement to develop ZED1227/TAK-227, a Phase 2b investigational therapy for the treatment of celiac ...
- 2022년 10월 21일
-
- Approval of extension of exemptions from SIX disclosure and publicity obligations
- Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma AG (Vifor) announced today that by decision dated October 19, 2022, SIX Exchange Regulation AG (SER) has approved an extension of the ...
- 2022년 10월 20일
전시회
